Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?
Mao Z, Álvarez-Gonzalez C, De Trane S, Yildiz O, Albor C, Doctor G, Soon D, Pepper G, Turner BP, Marta M, Mathews J, Giovannoni G, Baker D, Schmierer K.
Mao Z, et al. Among authors: albor c.
Mult Scler J Exp Transl Clin. 2018 Jun 26;4(2):2055217318783767. doi: 10.1177/2055217318783767. eCollection 2018 Apr-Jun.
Mult Scler J Exp Transl Clin. 2018.
PMID: 30090639
Free PMC article.